Literature DB >> 24651956

Circumferential resection margin (CRM) positivity after MRI assessment and adjuvant treatment in 189 patients undergoing rectal cancer resection.

G S Simpson1, N Eardley, F McNicol, P Healey, M Hughes, P S Rooney.   

Abstract

PURPOSE: The management of rectal cancer relies on accurate MRI staging. Multi-modal treatments can downstage rectal cancer prior to surgery and may have an effect on MRI accuracy. We aim to correlate the findings of MRI staging of rectal cancer with histological analysis, the effect of neoadjuvant therapy on this and the implications of circumferential resection margin (CRM) positivity following neoadjuvant therapy.
METHODS: An analysis of histological data and radiological staging of all cases of rectal cancer in a single centre between 2006 and 2011 were conducted.
RESULTS: Two hundred forty-one patients had histologically proved rectal cancer during the study period. One hundred eighty-two patients underwent resection. Median age was 66.6 years, and male to female ratio was 13:5. R1 resection rate was 11.1%. MRI assessments of the circumferential resection margin in patients without neoadjuvant radiotherapy were 93.6 and 88.1% in patients who underwent neoadjuvant radiotherapy. Eighteen patients had predicted positive margins following chemoradiotherapy, of which 38.9% had an involved CRM on histological analysis.
CONCLUSIONS: MRI assessment of the circumferential resection margin in rectal cancer is associated with high accuracy. Neoadjuvant chemoradiotherapy has a detrimental effect on this accuracy, although accuracy remains high. In the presence of persistently predicted positive margins, complete resection remains achievable but may necessitate a more radical approach to resection.

Entities:  

Mesh:

Year:  2014        PMID: 24651956     DOI: 10.1007/s00384-014-1846-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.

Authors:  Eisar Al-Sukhni; Laurent Milot; Mark Fruitman; Joseph Beyene; J Charles Victor; Selina Schmocker; Gina Brown; Robin McLeod; Erin Kennedy
Journal:  Ann Surg Oncol       Date:  2012-01-20       Impact factor: 5.344

3.  Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit.

Authors:  P Videhult; K Smedh; P Lundin; W Kraaz
Journal:  Colorectal Dis       Date:  2007-06       Impact factor: 3.788

4.  Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.

Authors: 
Journal:  Radiology       Date:  2007-02-28       Impact factor: 11.105

5.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

6.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?

Authors:  Atthaphorn Trakarnsanga; Mithat Gonen; Jinru Shia; Karyn A Goodman; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2013-01-18       Impact factor: 5.344

8.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

9.  The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.

Authors:  Koen C M J Peeters; Corrie A M Marijnen; Iris D Nagtegaal; Elma Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm Rutten; Lars Pahlman; Bengt Glimelius; Jan Willem Leer; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

10.  Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction.

Authors:  Roy F A Vliegen; Geerard L Beets; Guido Lammering; Raphaëla C Dresen; Harm J Rutten; Alfons G Kessels; Toen-Khiam Oei; Adriaan P de Bruïne; Jos M A van Engelshoven; Regina G H Beets-Tan
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

View more
  6 in total

Review 1.  MRI Local Staging and Restaging in Rectal Cancer.

Authors:  Gregory dePrisco
Journal:  Clin Colon Rectal Surg       Date:  2015-09

Review 2.  Adjuvant chemotherapy for rectal cancer: Is it needed?

Authors:  Kristijonas Milinis; Michael Thornton; Amir Montazeri; Paul S Rooney
Journal:  World J Clin Oncol       Date:  2015-12-10

3.  Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.

Authors:  Francesco Sclafani; Gina Brown; David Cunningham; Sheela Rao; Paris Tekkis; Diana Tait; Federica Morano; Chiara Baratelli; Eleftheria Kalaitzaki; Shahnawaz Rasheed; David Watkins; Naureen Starling; Andrew Wotherspoon; Ian Chau
Journal:  Oncologist       Date:  2017-05-05

4.  Can Post-Treatment MRI Features Predict Pathological Circumferential Resection Margin (pCRM) Involvement in Low Rectal Tumors.

Authors:  A Patra; A D Baheti; S K Ankathi; A Desouza; R Engineer; V Ostwal; A Ramaswamy; A Saklani
Journal:  Indian J Surg Oncol       Date:  2020-09-22

5.  Can CRM Status on MRI Predict Survival in Rectal Cancers: Experience from the Indian Subcontinent.

Authors:  Mihir Chandarana; Supreeta Arya; Jean-Louis de Menezes; Reena Engineer; Vikas Ostwal; Prachi Patil; Suman Kumar; Rohit Dusane; Ashwin D'souza; Avanish Saklani
Journal:  Indian J Surg Oncol       Date:  2019-02-21

6.  The significance of extramural venous invasion in R1 positive rectal cancer.

Authors:  N M Ormsby; H N Bermingham; H M Joshi; M Chadwick; A Samad; D Maitra; M Scott; S Kelly; K Whitmarsh; R Rajaganeshan
Journal:  Int J Colorectal Dis       Date:  2016-10-01       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.